Actavis

Activities: Manufacturing Pharmaceutical

Trending Articles

  1. IMPACT CKD model reveals the escalating toll of chronic kidney disease The model projects up to 125 million of the population across eight countries to suffer from chronic kidney disease by 2032
  2. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  3. Isospec Analytics launches biomolecular analysis technology to identify unknown molecules The novel technology optimises the identification process of unknown molecules compared to mass analysis
  4. Building strong foundations for a resilient and planet-friendly future Having recently released its inaugural environmental, social and governance (ESG) report, Dr Kevin Robinson caught up with Gigi Bat-Erdene, Global ESG Program Manager at PCI...
  5. ten23 health and Ypsomed collaborate to commercialise the YpsoDose patch injector The partnership will bring the drug delivery device to the pharmaceutical market quicker, whilst reducing development risks

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Regulatory

Pharma companies fined £45m for 'pay-for-delay'

GSK’s conduct, in making payments to induce companies to delay their efforts to enter the UK paroxetine market infringed the competition law prohibition on abuse of a dominant position
Regulatory

Schizophrenia – cariprazine

Drug treatment for schizophrenia has relied for many years on antipsychotics such as chlorpromazine and haloperidol, but side-effects limited their usefulness, particularly in terms of compliance
Finance

Amneal to purchase generics business of Actavis Australia

Financial terms are not disclosed by the companies
Regulatory

Actavis gets go-ahead from European Commission to purchase Allergan

Deal will create one of the top 10 global pharmaceutical companies by sales revenue
Finance

Actavis plans to change name to Allergan after acquisition closes

Will retain Actavis name for certain geographic regions and product portfolios
Research & Development

Actavis to divest Pharmatech to TPG

TPG to focus on growth and development of innovative products
Regulatory

Nearly 90,000 Gabapentin capsules are recalled by Aurobindo Pharma and Actavis

The capsules were manufactured at two plants in India
Subscribe now